- Home
- IMNN vs REBN Comparison
IMNN vs REBN Comparison
Compare IMNN & REBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNN
- REBN
- Stock Information
- Founded
- IMNN 1982
- REBN 2015
- Country
- IMNN United States
- REBN United States
- Employees
- IMNN N/A
- REBN N/A
- Industry
- IMNN Biotechnology: Pharmaceutical Preparations
- REBN Restaurants
- Sector
- IMNN Health Care
- REBN Consumer Discretionary
- Exchange
- IMNN Nasdaq
- REBN Nasdaq
- Market Cap
- IMNN 12.1M
- REBN 12.8M
- IPO Year
- IMNN 1985
- REBN 2022
- Fundamental
- Price
- IMNN $6.53
- REBN $3.06
- Analyst Decision
- IMNN Buy
- REBN
- Analyst Count
- IMNN 2
- REBN 0
- Target Price
- IMNN $182.61
- REBN N/A
- AVG Volume (30 Days)
- IMNN 244.8K
- REBN 88.6K
- Earning Date
- IMNN 08-05-2025
- REBN 08-14-2025
- Dividend Yield
- IMNN N/A
- REBN N/A
- EPS Growth
- IMNN N/A
- REBN N/A
- EPS
- IMNN N/A
- REBN N/A
- Revenue
- IMNN N/A
- REBN $6,565,623.00
- Revenue This Year
- IMNN N/A
- REBN $335.98
- Revenue Next Year
- IMNN N/A
- REBN N/A
- P/E Ratio
- IMNN N/A
- REBN N/A
- Revenue Growth
- IMNN N/A
- REBN 14.03
- 52 Week Low
- IMNN $4.83
- REBN $1.03
- 52 Week High
- IMNN $41.22
- REBN $8.30
- Technical
- Relative Strength Index (RSI)
- IMNN 40.89
- REBN 58.80
- Support Level
- IMNN $6.17
- REBN $2.80
- Resistance Level
- IMNN $7.21
- REBN $3.24
- Average True Range (ATR)
- IMNN 0.51
- REBN 0.24
- MACD
- IMNN 0.14
- REBN 0.03
- Stochastic Oscillator
- IMNN 20.45
- REBN 60.22
About IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).
About REBN Reborn Coffee Inc.
Reborn Coffee Inc is an operator and franchisor of retail locations and kiosks that focus on serving specialty-roasted coffee. It is an company that strives for constant improvement in the coffee experience through exploration of new technology and premier service, guided by traditional brewing techniques. The company operates in one reportable segment, consisting of both the wholesale and retail sales of coffee, water, and other beverages.